Unlocking Insights: Cross-Study Analysis of SEND Datasets with Xbiom™
For those who couldn’t join us live, we’re excited to share the recording of our third SEND webinar! This session focused on Cross-Study Analysis of SEND Datasets using Xbiom™, where we covered everything from building a solid study repository to...
Webinar on Visualization of SEND datasets
Date: Wednesday, July 31st, 2024Time: 09:00 AM PT / 12:00 PM ET PointCross Life Sciences held a webinar on Visualizing your SEND datasets. What we covered: This session is tailored for professionals in QC, data analysis, or study management, offering hands-on tips...
Clinical Research Metadata Management Repository : The Role of Xbiom by PointCross
In the fast-paced world of clinical research, managing metadata effectively is crucial. That’s where the Xbiom Metadata Management Repository (MDR) by PointCross comes in, offering a comprehensive solution for both clinical and nonclinical metadata needs. In this blog, we’ll delve...
Webinar on The Most Common Issues in Preparing SEND: Explained
In this webinar, we discussed how SEND-ASSURE ensures consistency with the audited Study Report, conformance to Technical Rejection Criteria guidelines, and follows details of the Technical Conformance Guide as the trusted references for data submission and regulatory compliance. Key Takeaways: Submit with...
PointCross attends Verisian first community event in Hyderabad
We’re thrilled to share that our team members, Raja and Arpitha, recently had the privilege to attend Verisian’s first community event in Hyderabad. During the event, we had the opportunity to present on: “Leveraging LLMs for Traceable Metadata Specifications and...
Interim Nonclinical Study Monitoring with Xbiom™ Insights
In nonclinical studies, waiting until the completion of a study to make data-driven decisions may limit the potential for valuable insights. Traditional study reports published post-completion often lack the ability to provide on-study analysis and early indicators crucial for driving...
